Browsing by Author "Kim, Hyun Sue"

Now showing 1 - 3 of 3
  • Thumbnail Image
    False-Positive Phencyclidine (PCP) Result on 11-Panel Urine Drug Screen (UDS) in a 17-Year-Old Adolescent with Long-Term Venlafaxine Use
    Kim, Hyun Sue; Jain, Aakash; Kablinger, Anita S. (Hindawi, 2023-06-26)
    Venlafaxine is an antidepressant belonging to the class of serotonin–norepinephrine reuptake inhibitors that are US Food and Drug Administration-approved to treat and manage symptoms of depression, anxiety, and other mood disorders in adults. We describe an adolescent patient who likely had a false-positive phencyclidine result detected with an 11-panel urine drug screen in an outpatient setting of long-term use of therapeutic venlafaxine extended release for the treatment of recurrent major depressive disorder and generalized anxiety disorder. We believe that this may be the first published case report to characterize this phenomenon in a young patient in the absence of an acute overdose.
  • Thumbnail Image
    Time to Reconsider Hepatitis A Vaccination in Food Handlers: Are We Seeing More Outbreaks and Severe Disease?
    Kim, Hyun Sue; Torres, Jordan Lydia; Baffoe-Bonnie, Anthony (Oxford University Press, 2022-04-12)
    The risk for secondary infection from hepatitis A-infected food handlers to patrons is deemed as low. Thus, hepatitis A vaccination is not specifically recommended for persons who handle food in the absence of other risk factors in the United States. We describe an ongoing food handler-associated hepatitis A outbreak in southwest Virginia and recommend policy changes that will incentivize food industry employers to embrace broader food handler hepatitis A vaccination.
  • Thumbnail Image
    When Should Healthcare Workers With Coronavirus Disease 2019 (COVID-19) Return to Work? An Analysis of Follow-up Antigen Test Results After a Positive COVID Test
    Baffoe-Bonnie, Anthony W.; Swann, Mandy C.; Kim, Hyun Sue (Oxford University Press, 2023-03-03)
    A high percentage of healthcare workers (HCWs) who had met the Centers for Disease Control and Prevention criteria for returning to work 5 days after symptom onset remained positive for their return-to-work COVID-19 antigen test, suggesting continued infectiousness. Boosted HCWs were more likely to be antigen positive on their return-to-work test compared to unvaccinated HCWs, which merits further research.